Issue opens for subscription on 27.07.15 and will close on 29.07.15. Minimum application is to be made for 60 shares and in multiples thereon, thereafter.
SIL is engaged in contract based discovery, development and manufacturing at its ultra modern world class research and development facility. 95% of its revenue comes from global clients and the rest from domestic clients. As claimed in RHP by promoters and merchant bankers, there are no listed peers to compare with.
Read more at: http://economictimes.indiatimes.com/markets/ipos/fpos/top-five-reasons-why-long-term-investors-should-subscribe-to-syngene-ipo/articleshow/48212739.cms